Immunogenetic susceptibility to diabetes mellitus in patients with liver disease

Liver International

Volumn 29, Issue 10, 2009, Pages 1543-1551

  Montano Loza, Aldo J ^a   Sultan, Aqib ^b   Falanga, Debbie ^b   Loss, George ^b   Mason, Andrew L ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Chronic liver disease; Diabetes mellitus; HCV; HLA

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR2 ANTIGEN; HLA DR5 ANTIGEN; HLA DR6 ANTIGEN;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEREDITY; HLA TYPING; HUMAN; IMMUNOGENETICS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE;

ADULT; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE SUSCEPTIBILITY; FEMALE; GENES, MHC CLASS I; GENES, MHC CLASS II; HAPLOTYPES; HEPATITIS C; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HLA-DR2 ANTIGEN; HUMANS; LIVER DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 73349108453     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02095.x     Document Type: Article

References (46)

1. Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts E.H. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002; 17: 677-81.
2. Hickman IJ, Macdonald G.A. Impact of diabetes on the severity of liver disease. Am J Med 2007; 120: 829-34.
3. Petrides A.S. Liver disease and diabetes mellitus. Diabetes Rev 1994; 2: 2-18.
4. Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-9.
5. Poonawala A, Nair SP, Thuluvath P.J. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000; 32: 689-92.
6. Allison MED, Wreghitt T, Palmer CR, Alexander G.J.M. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-9.
7. Caronia S, Taylor K, Pagliaro L, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.
8. Gray A, Wreghitt T, Stratton IM, et al. High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabetic Med 1995; 12: 244-9.
9. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000; 75: 355-9.
10. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-33.
11. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
12. Wang CS,Wang ST, Yao WJ, Chang TT, Chou P. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol 2007; 166: 196-203.
13. Daneman D. Type 1 diabetes. Lancet 2006; 367: 847-58.
14. Todd JA,Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857-64.
15. Wicker LS, Clark J, Fraser HI, et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun 2005; 25: 29-33.
16. Groop L, Groop PH, Koskimies S. Relationship between Bcell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 1986; 29: 757-60.
17. Horton V, Stratton I, Bottazzo GF, et al. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group. Diabetologia 1999; 42: 608-16.
18. Rich SS, French LR, Sprafka JM, Clements JP, Goetz F.C. HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study. Diabetologia 1993; 36: 234-8.
19. Tuomilehto-Wolf E, Tuomilehto J, Hitman GA, et al. Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region. BMJ 1993; 307: 155-9.
20. Wilkin T.J. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001; 44: 914-22.
21. Fajans S. Classification and diagnosis of diabetes. In: Rifkin H, Porte D, eds. Diabetes Mellitus: Theory and Practice, 4 edn. New York: Elsevier, 1990; 346-56.
22. Wei YL, Detre KM, Everhart J.E. The NIDDK liver transplantation database. Liver Transpl Surg 1997; 3: 10-22.
23. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119-34.
24. Olerup O, Zetterguist H. DR ''low-resolution'' PCR-SSP typing - a correction and an up-date. Tissue Antigens 1993; 41: 55-6.
25. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
26. Gorski J, Rollini P, Mach B. Structural comparison of the genes of two HLA-DR supertypic groups: the loci encoding DRw52 and DRw53 are not truly allelic. Immunogenetics 1987; 25: 397-402.
27. Noble JA, Valdes AM, Cook M, et al. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134-48.
28. Nepom GT, KwokWW. Perspectives in diabetes: molecular basis for HLA-DQ associations with IDDM. Diabetes 1998; 47: 1177-84.
29. McDevitt H.O. The role of MHC class II molecules in susceptibility and resistance to autoimmunity. Curr Opin Immunol 1998; 10: 677-81.
30. Nakanishi K, Kobayashi T, Murase T, et al. Human leukocyte antigen-A24 and -DQA1*0301 in Japanese insulindependent diabetes mellitus: independent contributions to susceptibility to the disease and additive contributions to acceleration of beta-cell destruction. J Clin Endocrinol Metab 1999; 84: 3721-5.
31. Redondo MJ, Fain PR, Eisenbarth G.S. Genetics of type 1A diabetes. Recent Prog Horm Res 2001; 56: 69-89.
32. Price P, Cheong KY, Boodhoo A, et al. Can MHC class II genes mediate resistance to type 1 diabetes? Immunol Cell Biol 2001; 79: 602-6.
33. Tueche S.G. Diabetes mellitus after liver transplant new etiologic clues and cornerstones for understanding. Transplant Proc 2003; 35: 1466-8.
34. De Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human M.H.C. Nat Genet 2006; 38: 1166-72.
35. Cao K, Hollenbach J, Shi X, et al. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 2001; 62: 1009-30.
36. Oruc S, Duffy BF, Mohanakumar T, Kaplan H.J. The association of HLA class II with pars planitis. Am J Ophthalmol 2001; 131: 657-9.
37. Sanjeevi CB, Lybrand TP, Landin-Olsson M, et al. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus. Tissue Antigens 1994; 44: 110-9.
38. Song EY, Kang SJ, Lee YJ, Park M.H. HLA-DR2-associated DRB1 and DRB5 alleles and haplotypes in Koreans. Hum Immunol 2000; 61: 937-41.
39. Voorter CE, Roeffaers HE, Du Toit ED, Van den Berg-Loonen E.M. The absence of DR51 in a DRB5-positive individual DR2ES is caused by a null allele (DRB5*0108N). Tissue Antigens 1997; 50: 326-33.
40. Diekman LA,Wells TD, Reveille JD, Moulds J.M. Frequency of HLA-DQB*06 in Caucasian, African American, and Mexican American patients with a positive direct antiglobulin test. Immunohematology 2000; 16: 74-7.
41. Picardi A, D'Avola D, Gentilucci UV, et al. Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev 2006; 22: 274-83.
42. Grimbert S, Valensi P, Levy-Marchal C, et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case control study. Gastroenterol Clin Biol 1996; 20: 544-8.
43. Konrad T, Zeuzem S, Vicini P, et al. Evaluation of factors controlling glucose tolerance in patients with HCVinfection before and after 4 months therapy with interferon-a. Eur J Clin Invest 2000; 30: 111-21.
44. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-8.
45. Hui JM, Sud A, Farrell GC, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003; 125: 1695-704.
46. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 1995; 108: 157-64.